Lyon Joseph Douglas, Chief Accounting&Technology Officer exercised 3,357 shares of CORCEPT THERAPEUTICS INC ($CORT) @ $13.56 ($45,520.92 total) on Oct 2, 2026

Lyon Joseph Douglas – Chief Accounting&Technology Officer

Oct 2, 2026

52W Low$28.66

Current$122.0395.5% above low, 4.5% below high

Purchase$13.56-15.5% above low, 115.5% below high

52W High$126.38

3,357

Price

$13.56

Total Value

$45,520.92

Nearby Earnings

No earnings within 2 weeks of this transaction.

Insider	Lyon Joseph Douglas
Title	Chief Accounting&Technology Officer
Transaction Date	Oct 2, 2026
Transaction Code	M Exercise/Conversion
Acquired/Disposed	Acquired
Security	Common Stock
Direct/Indirect	Direct
Filing Date	Oct 5, 2026
Shares Purchased	3,357
Price per Share	$13.56
Total Value	$45,520.92
Shares Owned After	9,040
Derivative	No
Accession Number	0001193125-26-414684
Document	View SEC Filing